CA2176603A1 - Nouveaux complexes de palladium et leurs procedes d'utilisation dans le traitement des tumeurs et du psoriasis - Google Patents

Nouveaux complexes de palladium et leurs procedes d'utilisation dans le traitement des tumeurs et du psoriasis

Info

Publication number
CA2176603A1
CA2176603A1 CA002176603A CA2176603A CA2176603A1 CA 2176603 A1 CA2176603 A1 CA 2176603A1 CA 002176603 A CA002176603 A CA 002176603A CA 2176603 A CA2176603 A CA 2176603A CA 2176603 A1 CA2176603 A1 CA 2176603A1
Authority
CA
Canada
Prior art keywords
psoriasis
same
tumors
treatment
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002176603A
Other languages
English (en)
Other versions
CA2176603C (fr
Inventor
Merrill Garnett
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GARNETT MCKEEN LABORATORY Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/157,570 external-priority patent/US5463093A/en
Application filed by Individual filed Critical Individual
Publication of CA2176603A1 publication Critical patent/CA2176603A1/fr
Application granted granted Critical
Publication of CA2176603C publication Critical patent/CA2176603C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/02—Five-membered rings
    • C07D339/04—Five-membered rings having the hetero atoms in positions 1 and 2, e.g. lipoic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/006—Palladium compounds
    • C07F15/0066—Palladium compounds without a metal-carbon linkage

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002176603A 1993-11-26 1994-11-17 Nouveaux complexes de palladium et leurs procedes d'utilisation dans le traitement des tumeurs et du psoriasis Expired - Fee Related CA2176603C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/157,570 US5463093A (en) 1993-11-26 1993-11-26 Palladium complexes and methods for using same in the treatment of tumors or Psoriasis
US08/157,570 1993-11-26
PCT/US1994/013260 WO1995014466A1 (fr) 1993-11-26 1994-11-17 Nouveaux complexes de palladium et leurs procedes d'utilisation dans le traitement des tumeurs et du psoriasis

Publications (2)

Publication Number Publication Date
CA2176603A1 true CA2176603A1 (fr) 1995-06-01
CA2176603C CA2176603C (fr) 2007-01-23

Family

ID=37684131

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002176603A Expired - Fee Related CA2176603C (fr) 1993-11-26 1994-11-17 Nouveaux complexes de palladium et leurs procedes d'utilisation dans le traitement des tumeurs et du psoriasis

Country Status (1)

Country Link
CA (1) CA2176603C (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114807616A (zh) * 2022-04-27 2022-07-29 南京桦冠生物技术有限公司 一种从含钯有机废液中回收富集钯的方法

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114807616A (zh) * 2022-04-27 2022-07-29 南京桦冠生物技术有限公司 一种从含钯有机废液中回收富集钯的方法
CN114807616B (zh) * 2022-04-27 2023-11-28 南京桦冠生物技术有限公司 一种从含钯有机废液中回收富集钯的方法

Also Published As

Publication number Publication date
CA2176603C (fr) 2007-01-23

Similar Documents

Publication Publication Date Title
CA2258548A1 (fr) Derives tricycliques substitues par phenylamino, destines au traitement des maladies hyperproliferatives
CA2257448A1 (fr) Amides pyridyl-alcene et pyridyl-alcyne acides utilises comme cytostatiques et immunosuppresseurs
CA2144312A1 (fr) Acides aliphatiques dicarboxyliques non satures
HU9401411D0 (en) Bile acid derivatives, process for producing them and pharmaceutical compositions containing them
IL109604A0 (en) Substituted mono- and bipyridylmethyl- pyridones, process for their preparation and pharmaceutical compositions containing them
HUT54052A (en) Process for producing stabile, cosmetically acceptable, topical gel composition for treating akne
CA2180535A1 (fr) Procede de traitement du psoriasis par omeprazole ou autres composes apparentes
AU3342097A (en) New pyridyl alkane acid amides as cytostatics and immunosuppressives
IE802744L (en) Platinum (iv)-diamine complexes
CA2019404A1 (fr) 11-beta-aryl-4-estrenes, procede de preparation et utilisation comme agents pharmaceutiques
CA2047237A1 (fr) Derives du chromane
HUT48624A (en) Process for producing 6-benzoxazinyl- and 6-benzothiazinyl-2,3,4,5-tetrahydropyridazin-3-ones and pharmaceutical compositions comprising such compounds
AU6857887A (en) Therapeutic agent
EP0934748A3 (fr) Préparation contenant le facteur de Von Willebrand (vWF), procédé pour préparer des compositions contenant le vWF et utilisation de ces compositions
AU7239794A (en) Process for preparing 5,8-dihydronaphthoquinone derivatives, novel 5,8-dihydronaphthoquinone derivatives and their use as anticancer agent
HUT41259A (en) Process for preparing pharmaceutical compositions in solide phase containing derivatives of dihydropyridine
HU9402292D0 (en) New baccatine-iii and 10-deacetyl-baccatine-iii derivatives, process for producing them and pharmaceutical compositions containing them as active component
IL129616A0 (en) Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
HUT62785A (en) Process for producing pharmaceutical compositions comprising trinitrobenzenes and carminic acid, suitable for treating cancer and viral diseases
HU9201799D0 (en) New 2-amino-5-ciano-1,4-dihydropiridine-derivatives, process for their use and their use as medicaments
HUT47096A (en) Process for producing 1,2-dithiol-3-thion derivatives and pharmaceutical compositions containing them as active components
CA2176603A1 (fr) Nouveaux complexes de palladium et leurs procedes d'utilisation dans le traitement des tumeurs et du psoriasis
MY114693A (en) Substituted benzenesulfonylureas and thioureas,processes for their preparation,their use for the production of pharmaceutical preparations, and pharmaceutical preparation containing them
CA2003981A1 (fr) Composes pharmaceutiques utiles dans le traitement du psoriasis
HUT46364A (en) Process for producing 1,12-dihydroxy-1,6,12,13-tetraaza-dicyclodocosane-2,5,13,16-tetron and pharmaceutical compositions comprising this compound as active ingredient

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20141117